Thursday, November 01, 2007 4:23:12 PM
[November 1, 2007 Bruker BioSpin]
Billerica, Massachusetts, November 1, 2007
Bruker BioSpin is pleased to announce the launch of its Bruker Analytical Services program, offering for-fee analytical measurements. The wide range of techniques currently includes NMR, FTIR and Raman spectroscopy, while expansions into additional techniques are planned. Our state of the art laboratories provide customers with direct access to the latest Bruker technologies, operated by our knowledgeable applications experts to assure the highest quality service with a quick turn around. The Bruker Analytical Services program will enable customers to lower infrastructure costs at their laboratory site, while still obtaining high quality information for their research applications.
"Early service opportunities highlight our strengths in NMR, TD-NMR, and FTIR applications," said Paul Dawson, Sales Manager for the Bruker Analytical Services Division. "With demand coming from such widespread markets as Pharmaceutical, Biotech, Petroleum industry and Academia, we are expanding our capabilities every day with resources from the entire Bruker family of technologies."
By opening the door to the vast resources of both the technology and the people that make Bruker a leader in the instrumentation industry, Bruker Analytical Services provides a powerful asset of innovation, excellence, and quality to a wide variety of project needs.
About Bruker BioSpin
The global Bruker BioSpin group designs, manufactures and distributes enabling life science and analytical research tools based on magnetic resonance core technology. The Company?s technology platforms include NMR, EPR, MRI, as well as superconducting magnets and superconducting wire. Bruker BioSpin's NMR division is the worldwide technology and market leader in NMR. For more information, please visit www.bruker-biospin.com.
http://www.spectroscopynow.com/coi/cda/detail.cda?id=17485&type=News&chId=2&page=1
Recent BRKR News
- Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery • Business Wire • 10/02/2024 11:00:00 AM
- Bruker Corporation to Present at Upcoming Investor Conferences • Business Wire • 08/23/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:39:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/15/2024 09:41:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:40:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:39:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:38:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:37:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:36:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:35:48 PM
- Bruker Announces Successful Installation of 1.2 GHz Avance® NMR Spectrometer at the Korea Basic Science Institute (KBSI) • Business Wire • 08/13/2024 05:35:00 PM
- Bruker Announces Quarterly Dividend • Business Wire • 08/12/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:07:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:03:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 12:30:50 PM
- Bruker Announces Strategic Minority Investment in NovAliX • Business Wire • 08/07/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:00:08 AM
- Bruker Reports Second Quarter 2024 Financial Results • Business Wire • 08/06/2024 11:00:00 AM
- Bruker Announces Date and Time of Second Quarter 2024 Earnings Release and Webcast • Business Wire • 07/31/2024 08:05:00 PM
- Bruker Announces that Injunction Impacting NanoString’s CosMx Spatial Molecular Imager Products in Germany Has Been Suspended Effective Immediately • Business Wire • 07/18/2024 11:00:00 AM
- Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin • Business Wire • 07/02/2024 11:00:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/05/2024 08:30:30 PM
- Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications • Business Wire • 06/03/2024 11:00:00 AM
- Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics • Business Wire • 06/03/2024 11:00:00 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM